These Rare Fork-Nosed Dogs Could Help Solve a Genetic Mystery in Humans
In a recent study, researchers say they've found the genetic mutation that causes these dogs to develop their characteristic split nose. They argue that similar mutations might also explain some cases of cleft lip and palate in humans.
An international research team conducted the study, including scientists from the National Institutes of Health in the U.S. and the KTH Royal Institute of Technology in Stockholm, Sweden. They analyzed the genetics of some 2,000 dogs, eventually discovering several new gene variants linked to a dog's facial structure and size. One of these variants was found in the Turkish Pointer, also known as the Catalburun.
The mutation concerns the gene PDFGRA. The researchers say that the gene seems to help connect the two halves of the face and mouth during embryonic development, with the unique variant in Turkish Pointers explaining their split-nose appearance.
'This indicates that the gene might be involved in some cases of human orofacial clefts,' said study researcher Peter Savolainen, a canine geneticist at KTH, in a statement from the institute. 'While there are several genetic and environmental reasons behind orofacial clefts in humans, this study offers a clue to another factor.'
The team's findings were published earlier this March in the journal Genome Research.
Facial clefts, which can involve the lips and/or palate, are thought to occur in one out of every 700 births. If untreated, the condition can hamper a person's feeding and speaking and raise the risk of ear infections. These days, thankfully, it can usually be repaired very successfully with surgery. Most cases of facial clefts have no clear cause, though factors like smoking, diabetes, and the use of certain medications during pregnancy seem to increase the risk.
As their name suggests, Turkish Pointers have primarily been bred in select parts of Turkey. They're said to be incredibly good sniffers, but they're also rare, with only a few hundred specimens thought to be living today (the breed isn't even officially recognized by any kennel club). Their tiny population numbers do raise the risk of genetic disease, though this is an issue with purebred dogs in general. But these dogs and other rare breeds also make it easier for scientists to isolate genes and mutations relevant to human health, the authors say.
'Studying the very inbred dog breeds is an excellent tool for finding the genetic reason for many morphologic traits and diseases in humans,' Savolainen said. 'In humans there is just too much genetic variation, making it hard to identify exactly which genetic mutation causes a specific disease.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Human Babies Aren't Supposed to Have 3 Parents—but Now They Can
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: The first babies with three biological parents were born out of a new technique to prevent mitochondrial disease. The nucleus of an egg fertilized in vitro was transferred into a donor egg without a nucleus, but with viable mitochondria. Eight healthy babies, including a set of twins, were born with low to undetectable levels of mitochondrial mutations. The only creatures known to conceive offspring from more than two parents are salamanders. Females from the genus Ambystoma (which are notoriously promiscuous) mate with up to three different males, and that DNA is then incorporated into what is known as a triploid genome in their offspring. Now a version of this has become possible in humans. It seems limb regeneration isn't the only way medical intervention can put humans on salamanders' level. Being born with three genomes is not a phenomenon that occurs naturally in Homo sapiens, but in an attempt to prevent certain genetic conditions caused by mutations in the mitochondria, scientists have found a way. Mitochondrial DNA or mtDNA is exclusively passed down from the maternal side. Dysfunction in the mitochondria can lead to metabolic diseases characterized by symptoms such as seizures, developmental delays, blindness, and loss of muscular function. Some can even be fatal. Mitochondrial diseases occur in about 1 in every 5,000 people. They were previously only preventable by using a donor egg or foregoing the conception of biological children altogether. This is why pediatric neurologist Bobby McFarland, of Newcastle University in the UK, led an experimental study that would reduce and potentially eliminate the risk of mitochondrial disease with a new method of in vitro fertilization. McFarland and his research team wanted see if removing the nucleus of an egg and placing it in a donor egg with viable mitochondria would result in healthy offspring. 'We found that pronuclear transfer, a form of mitochondrial donation, was effective in reducing the level of pathogenic mtDNA variant to substantially below the threshold for clinical disease in the offspring of women with homoplasmic (or high heteroplasmic) levels,' he said in a study recently published in the New England Journal of Medicine. When mitochondria are homoplasmic, all copies produced by cell division have mutations. Mutation levels vary in heteroplasmic mitochondria. Preimplantation genetic testing (PGT) can screen for these abonormalities, and women with homoplasmy or high levels of heteroplasmy can benefit from what is now known as pronuclear transfer. This involves eggs from both the mother and donor being fertilized with the father's sperm in vitro. Nuclei are then removed from both eggs after ten hours. Since the nucleus carries most genetic material and has no connection to mitochondrial disease, the mother's nucleus is implanted into the donor egg to take advantage of its mitochondria. While there is a chance that a few of the mother's mitochondria may end up in the embryo, it is unlikely to cause a debilitating disease. Levels of defective mitochondria in offspring conceived via pronuclear transfer were low enough to escape that fate. Eight pregnancies (including a set of twins) resulted from the experiment, and while there were a few minor health problems in the newborns, these were either treatable or corrected themselves. Not only were levels of heteroplasty low for the babies, but undetectable in five of them. Developmental progress also turned out to be normal. Though one baby had a form of infant epilepsy, and another had heart arrhythmia and hyperlipidemia, or high levels of fats and lipids in the blood, both of these conditions were treated and resolved. Whether the hyperlipidemia was even caused by mtDNA is uncertain, especially because the mother also had severe hyperlipidemia during her pregnancy. Though there was a chance that any of the mothers with pathogenic mtDNA had a higher risk of complications during pregnancy, which could possibly cause their children to have health issues, there is no proof for now. 'We are assessing, over the long term, the health and extent of heteroplasmy (if detectable) of the offspring,' McFarland and his team said. 'Indeed, the role of mitochondrial donation as a choice for women with a heritable pathogenic mtDNA variant will only be established with the availability of additional data.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword
The Hill
2 days ago
- The Hill
GOP senators urge White House to release delayed NIH funding
Sen. Katie Britt (R-Ala.) and 13 other Senate Republicans are urging the Trump administration to release National Institutes of Health (NIH) funding that has been held up for months. The GOP senators warned in a letter to White House budget chief Russell Vought that the 'slow disbursement of funds' that Congress appropriated in March 'risks undermining critical research and the thousands of American jobs it supports.' 'Suspension of these appropriated funds — whether formally withheld or functionally delayed — could threaten Americans' ability to access better treatments and limit our nation's leadership in biomedical science,' the senators warned. 'It also risks inadvertently severing ongoing NIH-funded research prior to actionable results,' they wrote. The Trump administration suspended or cut many NIH research grants earlier this year in order to undertake a thorough review to ensure they complied with Trump's orders to end federal support for diversity, equity and inclusion (DEI) programs. A database set up by a Harvard University researcher estimated that by the end of May more than 2,100 NIH grants worth more than $9 billion had been cancelled. NIH Director Jay Bhattacharya told senators in March at his confirmation hearing that his agency would restart grant reviews but an analysis by STAT, a health care news site, last month found that NIH had made little progress in narrowing the funding gap created by the freeze on grant approvals. Now Republican senators are trying to ramp up pressure on the Office of Management and Budget. They told Vought that they share his commitment to ensuring NIH funds are 'used responsibly and not diverted to ideological or unaccountable programs.' But they also argued that starving the NIH of funding could inadvertently undermine trust in the agency. 'Withholding or suspending these funds would jeopardize that trust and hinder progress on critical health challenges facing our nation. Ultimately, this is about finding cures and seeing them through to fruition,' the senators wrote. 'We respectfully request that you ensure the timely release of all FY25 NIH appropriations in accordance with congressional intent,' they added. The other GOP signatories were Sens. John Boozman (Ark.), Shelley Moore Capito ( Bill Cassidy (La.), Susan Collins (Maine), Lindsey Graham (S.C.), David McCormick (Pa.), Mitch McConnell (Ky.), Jerry Moran (Kansas), Lisa Murkowski (Alaska), Thom Tillis (N.C.), Todd Young (Ind.), Dan Sullivan (Alaska) and Tim Scott (S.C.).
CNN
2 days ago
- CNN
‘It's heartless, it's careless, and it's deeply damaging' says former NIH director on cuts to medical research
Dr. Francis Collins, former director of the National Institutes of Health, speaks to Christiane Amanpour about his decision to leave the agency and what he says is the Trump administration's crackdown on science.
